Skip to main content
SpringerLink
Log in

Characterization of anti-heart M2 muscarinic receptor antibodies — a combined clinical and experimental study

  • Part II: Cardiac Hypertrophy and Failure
  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

To elucidate the relationship between autoinimunity and idiopathic dilated cardiomyopathy has been one of today's heated topics in the field of heart research. So far it has been identified that there are a variety of autoantibodies including antireceptor autoantibodies. However, the role of these autoantibodies in the development of dilated cardiomyopathy has not been defined. An increasing number of in vitro studies showed that these autoantibodies had different functions, suggesting that they may play different roles in the pathogenesis of cardiomyopathy. The main purpose of this article is to briefly go through the results obtained from both clinical and experimental in vitro studies on anti-M2 muscarinic receptor antibodies to see where we stand in the understanding of the role of these autoantibodies in the pathogenesis of idiopathic dilated cardiomyopathy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Das SK, Cassidy JT, Petty RE: Antibodies against heart muscle and nuclear constituents in cardiomyopathy. Am Heart J 1972, 83: 159–166

    PubMed  Google Scholar 

  2. Caforio ALP, Bonifacio E, Stewart JT, Neglia D, Parodi O, Bottazzo GF, McKenna WJ: Novel organ-specific circulating cardiac autoantibodies in dilated cardiomyopathy. J Am Coll Cardiol 15: 1527–1534, 1990

    PubMed  Google Scholar 

  3. Latif N, Baker CS, Dunn MJ, Rose ML, Brady P, Yacoub MH: Frequency and specificity of antiheart antibodies in patients with dilated cardiomyopathy detected using SDS-PAGE and western blotting. J Am Coll Cardiol 22: 1378–1384, 1993

    PubMed  Google Scholar 

  4. Neumann DA, Burek CL, Baughman KL, Rose NR, Herskowitz A: Circulating heart-reactive antibodies in patients with myocarditis or cardiomyopathy. J Am Coll Cardiol 16: 839–846, 1990

    PubMed  Google Scholar 

  5. Caforio ALP, Grazzini M, Mann JM, Keeling PJ, Bottazzo GF McKenna WJ, Schiffino S: Identification of alpha and β myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation 85: 1734–172, 1992

    PubMed  Google Scholar 

  6. Schultheiss HP, Schwimmbeck P, Bolte FIDs Klingenberg M: The antigenic characteristics and the significance of the adenine nucleotide translocator as a major autoantigen to antimitochondrial antibodies in dilated cardiomyopathy. Adv Myocardiol 6: 311–327, 1985

    PubMed  Google Scholar 

  7. Schulze K, Becker BF, Schauer R, Schultheiss HP: Antibodies to ADPATP carrier-an autoantigen in myocarditis and dilated cardiomyopathy-impaired cardiac function. Circulation 81: 959–969, 1990

    PubMed  Google Scholar 

  8. Ansari AA, Herskowitz A, Danner DJ: Identification of mitochondrial proteins that serve as targets for autoimmunity in human dilated cardiomyopathy. Circulation 1988, 78 suppl 457

    Google Scholar 

  9. Klein R, Maisch B, Kochsiek K, Berg PA: Demonstration of organspecific antibodies against heart mitochondria (anti-M7) in sera from patients with some forms of heart diseases. Clin Exp Immunol 58: 283–292, 1984

    PubMed  Google Scholar 

  10. Ansari AA, Neckemann N, Villinger F, Leung P, Danner DJ, Brar SS, Zhao S, Gravanis MB, Mayne A, Gershwin ME, Herskowitz A: Epitope mapping of the branched chain alpha-ketoacid dehydrogenase dihydrolipoyl transacylase (BCKD-E2) protein that reacts with sera from patients with idiopathic dilated cardiomyopathy. J Immunol 153: 4754–4765, 1994

    PubMed  Google Scholar 

  11. Wolff PG, Kuhl U. Schultheiss HP: Laminin distribution and autoantibodies to laminin in dilated cardiomyopathy and myocarditis. Am Heart J 117: 1303–1309, 1989

    Article  PubMed  Google Scholar 

  12. Sterin-Borda LA, Cremaschi G, Pascual J, Genaro A, Borda E: Alloimmune lgG binds and modulates cardiac β-adrenergic receptors. Clin Exp Immunol 58: 223–228, 1984

    PubMed  Google Scholar 

  13. Limas CJ, Goldenberg IF, Limas C: Autoantibodies against β-adrenoreceptors in human dilated cardiomyopathy. Circ Res 64: 97–103, 1989

    PubMed  Google Scholar 

  14. Limas CJ, Limas C, Kubo SH, Olivari MT: Anti-β receptor antibodies in human dilated cardiomyopathy and correlation with HLA-DR antigens. Am J Cardiol 65: 483–487, 1990

    PubMed  Google Scholar 

  15. Magnusson Y, Marullo S, Hoyer S, Waagstein F, Andersson B, Vahln A, Guillet JG, Strosberg AD. Hjalmarson Å, Hoebeke J: Mapping of a functional autoimmune epitope on the β1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy. J Clin Invest 86: 1658–1663, 1990

    PubMed  Google Scholar 

  16. Wallukat G, Morwinski M, Kowal K, Forster A, Boewer V, Wollenberger A: Antibodies against the β-adrenergic receptor in myocarditis and cardiomyopathy: β-adrenergic agonism without desensitization. Eur Heart J 12 (suppl D): 178–181, 1991

    PubMed  Google Scholar 

  17. Limas CJ, Limas C. HLA-DR antigen linkage of anti-β receptor antibodies in idiopathic dilated and ischemic cardiomyopathy. Br Heart J 67: 402–405, 1992

    PubMed  Google Scholar 

  18. Fu LX, Magnusson Y, Bergh C-H, Liljeqvist J-Å, Waagstein F, Hjalmarson Å, Hoebeke J: Localization of a functional autoimmune epitope of second extracellular loop of the human muscarinic receptor in patients with idiopathic dilated cardiomyopathy. J Clin Invest 91: 1964–1968, 1993

    PubMed  Google Scholar 

  19. Fu LXM, Hoebeke J, Matsui S, Matoba M, Magnusson Y, Hedner T, Herlitz H, Hjalmarson Å: Autoantibodies against cardiac G-proteincoupled receptors define different populations with cardiomyopathies but not with hypertension. Clin Immunol Immunopathol 72: 15–20, 1994

    Article  PubMed  Google Scholar 

  20. Matsui S, Fu LXM, Shimizu M, Fukuoka T, Teraoka K, Takekoshi N, Murakami E, Hjalmarson Å: Dilated cardiomyopathy defines serum autoantibodies against G-protein coupled cardiovascular receptors. Autoimmunity 21: 85–88, 1995

    PubMed  Google Scholar 

  21. Fleming JW, Strawbridge RA, Watanabe AM: Muscarinic receptor regulation of cardiac adenylate cyclase activity. J Mol Cell Cardiol 19: 47–61, 1987

    PubMed  Google Scholar 

  22. Levine RR, Birdsall NJM (eds). Nomenclature for muscarinic receptor ] subtypes recommended by symposium. Trends Pharmacol Sci 10(suppl): VII, 1989

  23. Sterin-Borda L, Gorelik G, Borda ES: Chagasic 1gG binding with cardiac muscarinic cholinergic receptors modifies cholinergic-mediated cellular transmembrane signals. Clin Immunol Immunopathol 61: 387–391, 1991

    PubMed  Google Scholar 

  24. Fu LXM, Herlitz H, Wallukat G, Hilme E, Hedner T, Hoebeke J, Hjalmarson Å: A functional autoimmune epitope on alpha 1 adrenoceptors in patients with malignant hypertension. Lancet 344: 1660–1663, 1994

    Article  PubMed  Google Scholar 

  25. Fu LXM, Schulze W, Wallukat G, Hjalmarson Å, Hoebeke J: Functional epitope analysis of the second extracellular loop of the human heart muscarinic acetylcholine receptor. J Mol Cell Cardiol. 27: 427–436, 1995

    PubMed  Google Scholar 

  26. Fu LXM, Wallukat G, Hjalmarson A, Hoebeke J: Agonist-like activity of anti-peptide antibodies directed against an autoimmune epitope of human heart muscarinic acetylcholine receptor. Receptor and Channel 2: 121–130, 1994

    Google Scholar 

  27. Wang WZ, Zhao R, Wu BW, Fu LXM, Jin XH, Lin Z: Effects of antipeptide antibodies against human M2 muscarinic receptors on cardiac function in rats in vivo. Blood Pressure 1996 (in press)

  28. Wang WZ, Zhao R, Fu LXM, Lin Z, Jin XH: Effects of anti-peptide antibodies against M2 muscarinic receptors on the cAMP generating system in guinea-pig ventricles. Blood Pressure 1996 (in press)

  29. Zhao R, Wang WZ, Wu B, Hoebeke J, Hjalmarson A, Fu LXM: Effects of anti-peptide antibodies against the second extracellular loop of human M2 muscarinic acetylcholine receptors on transmembrane potentials and currents in guinea pig ventricular myocytes. Mol Cell Biochem 1996 (in press)

  30. Fu LXM, Schulze W, Wolf WP, Hjalmarson Å, Hoebeke J: Immunocytochemical localization of M2 muscarinic receptor in rat ventricles using anti-peptide antibodies. J Histochem Cytochem 42: 337–343, 1994

    PubMed  Google Scholar 

  31. Zhu L, Wang WZ, Jin XH, Zhao R, Fu LXM: Immunocytochemical studies of M2 muscarinic receptors in guinea-pig atria and ventricles using anti-peptide antibodies. Blood Pressure 1996 (in press)

  32. Schulze W, Fu LXM, Hoebeke J, Hjalmarson Å: Localization of muscarinic receptors in heart biopsies from patients with heart disease using rabbit antibodies against an autoimmune epitope on human M2 muscarinic receptors. J Mol Cell Cardiol 27: 1757–1764, 1995

    Article  PubMed  Google Scholar 

  33. Fu LXM, Herlitz H, Schulze W, Wallukat G, Hoebeke J, Hjalmarson Å: Autoantibodies against an extracellular domain on human angiotensin II receptor subtype 1 in patients with malignant hypertension (abstract). Circulation 1337: (suppl), 1995

Download references

Author information

Authors and Affiliations

  1. Wallenberg Laboratory, Sahlgren's Hospital, University of Göteborg, S-413 45, Goteborg, Sweden

    Michael L. X. Fu

Authors
  1. Michael L. X. Fu
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fu, M.L.X. Characterization of anti-heart M2 muscarinic receptor antibodies — a combined clinical and experimental study. Mol Cell Biochem 163, 343–347 (1996). https://doi.org/10.1007/BF00408675

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00408675

Key words

Search

Navigation